Ardent Health Partners (NYSE:ARDT) Releases FY 2025 Earnings Guidance

Ardent Health Partners (NYSE:ARDT) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.730-2.010 for the period, compared to the consensus earnings per share estimate of 1.930. The company issued revenue guidance of $6.2 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

Ardent Health Partners Stock Performance

Shares of ARDT traded down $0.49 during trading hours on Wednesday, reaching $13.96. 499,049 shares of the company traded hands, compared to its average volume of 369,997. The stock has a fifty day simple moving average of $15.29 and a 200 day simple moving average of $16.87. Ardent Health Partners has a fifty-two week low of $13.63 and a fifty-two week high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. Equities research analysts predict that Ardent Health Partners will post 1.23 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Morgan Stanley dropped their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. JPMorgan Chase & Co. restated a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Truist Financial dropped their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Leerink Partners lifted their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research report on Tuesday, November 12th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $21.55.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.